Trending Now
AI and Blockchain Converge with BLGI Inc (OTCMKTS:BLGI)
Two of the most important trends defining the intermediate-term future are starting to coalesce, as both blockchain and artificial intelligence are increasingly implicated in...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Gritstone bio Inc. (NASDAQ: GRTS) Expands Agreement With CEPI for self-amplifying...
Gritstone bio Inc. (NASDAQ: GRTS) has announced the expansion of its agreement with Coalition for Epidemic Preparedness Innovations, CEPI, supporting the creation of a...
MAKE IT MODERN
LATEST REVIEWS
Synthetic Biologics Inc (NYSE:SYN) begins Phase 1a Clinical Trial Of SYN-020...
Synthetic Biologics Inc (NYSE:SYN) began phase 1a clinical study of SYN-020 IAP (Intestinal Alkaline Phosphatase) by dosing the first six patients.
Cures inflammation in the...
MAKE IT MODERN
PERFORMANCE TRAINING
Futures turn green after the Iran saga
The Geopolitical uncertainty has simmered down, for the moment and The SPY moved up yesterday but has since fallen in premarket having...
Bitcoin is Back in Rally Mode, and these Stocks Stand to Benefit Most (RIOT,...
Bitcoin is back in gear this week with a major bullish technical breakout on Monday that takes BTC to new year-to-date highs...
Gilead Sciences Inc. (NASDAQ:GILD) Receives FDA Approval For Remdesivir In Treating COVID-19
The US FDA has approved Gilead Sciences Inc. (NASDAQ:GILD) antiviral therapy remdesivir for the treatment of COVID-19. This makes the drug the first to...
Chromadex Corp (NASDAQ:CDXC) Collaborates With NIH-NIAID to Support the Study of Its Patent-Protected NR...
The virus that causes COVID-19 can live for several hours and up to three days either in the air or on surfaces. This is...
TG Therapeutics Inc. (NASDAQ: TGTX) Presents Ublituximab Study Data Used To File For Biologics...
TG Therapeutics Inc. (NASDAQ: TGTX) has presented data that includes additional analyses from its Phase 3 trials, ULTIMATE I & II, evaluating its novel...
MAKE IT MODERN
